Eyebrow fillers The eyebrows are plump in youth. As the face ages, the supraorbital rim appears progressively more convex and the upper lid skin appears sagging to varying degrees. Medial and mid upper lid depressions due to fat atrophy are more common. The purpose of brow fillers is to restore the curvature and height of the eyebrow, elevate the upper lid skin, and improve the shape of the heavy lid. The brow filler can be done through a single entry point above the hairline or the tail of the eyebrow, where fine particles of fat are injected in dots of 0.1 ml each. the level of injection is superficial to the orbicularis oculi muscle. Infraorbital area filler There are two ways in which aging of the orbital area can manifest itself, the depressed type and the bulging type. In the depressed form, there is a decrease in the overall amount of tissue from the lid to the infraorbital rim. As the subcutaneous fat in the orbital area shrinks and the dermis thins, the orbicularis muscle becomes more visible under the skin, resulting in a deepening of the skin color and a dark circle formed by the projection of the eye and the orbicularis muscle; in the bulging form, the fat globules of the lower lid bulge out and often herniate out of the skin along with the orbital septum. In both of these cases, the lid-cheek continuity is interrupted and a lid-cheek furrow is formed. The level of fat injection in the infraorbital region is the deep surface of the orbicularis oculi, with the entry point being the lower central part of the cheek or the nasolabial fold, and a small amount of fat is injected from the inside out along the orbital rim. The entry point can also be in the middle and lateral side, which makes it easier to inject into the lateral suborbital and zygomatic areas. Avoid injecting into the subcutaneous layer to prevent sclerosis and unevenness of the skin. When treating patients with suborbital fat atrophy, the filler area should be from the lid plate to the orbital rim. Focus on filling the atrophic area for these patients. Hypertrophic suborbital aging is different because the tear trough area is full and injections should be avoided as much as possible. Suborbital injections should be conservative, with no more than 2 ml per side, and the transition to the junction area should be as natural as possible with microinjections.